Hollsteen
← Amphenol

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 2016: $3.4B · 10-Q 0001104659-16-118327 filed May 5, 2016Equity incl. NCI · Q2 2016: $3.6B · 10-Q 0001104659-16-136887 filed Aug 4, 2016Equity incl. NCI · Q3 2016: $3.8B · 10-Q 0001558370-16-009170 filed Nov 3, 2016Equity incl. NCI · Q4 2016: $3.7B · 10-K 0001558370-17-000659 filed Feb 17, 2017Equity incl. NCI · Q1 2017: $3.8B · 10-Q 0001558370-17-003547 filed May 4, 2017Equity incl. NCI · Q2 2017: $3.9B · 10-Q 0001558370-17-005866 filed Aug 3, 2017Equity incl. NCI · Q3 2017: $4.1B · 10-Q 0001558370-17-007980 filed Nov 2, 2017Equity incl. NCI · Q4 2017: $4.0B · 10-K 0001558370-18-000871 filed Feb 21, 2018Equity incl. NCI · Q1 2018: $4.0B · 10-Q 0001558370-18-003892 filed May 3, 2018Equity incl. NCI · Q2 2018: $3.8B · 10-Q 0001558370-18-005948 filed Jul 31, 2018Equity incl. NCI · Q3 2018: $4.1B · 10-Q 0001558370-18-007927 filed Oct 26, 2018Equity incl. NCI · Q4 2018: $4.1B · 10-K 0001558370-19-000636 filed Feb 13, 2019Equity incl. NCI · Q1 2019: $4.2B · 10-Q 0001558370-19-003426 filed Apr 26, 2019Equity incl. NCI · Q2 2019: $4.2B · 10-Q 0001558370-19-006415 filed Jul 26, 2019Equity incl. NCI · Q3 2019: $4.2B · 10-Q 0001558370-19-009160 filed Oct 25, 2019Equity incl. NCI · Q4 2019: $4.6B · 10-K 0001558370-20-000728 filed Feb 12, 2020Equity incl. NCI · Q1 2020: $4.4B · 10-Q 0001558370-20-004300 filed Apr 24, 2020Equity incl. NCI · Q2 2020: $4.8B · 10-Q 0001558370-20-008390 filed Jul 24, 2020Equity incl. NCI · Q3 2020: $5.1B · 10-Q 0001558370-20-011694 filed Oct 23, 2020Equity incl. NCI · Q4 2020: $5.5B · 10-K 0001558370-21-000881 filed Feb 10, 2021Equity incl. NCI · Q1 2021: $5.5B · 10-Q 0001558370-21-005338 filed Apr 30, 2021Equity incl. NCI · Q2 2021: $5.8B · 10-Q 0001558370-21-009700 filed Jul 30, 2021Equity incl. NCI · Q3 2021: $6.0B · 10-Q 0001558370-21-013825 filed Oct 29, 2021Equity incl. NCI · Q4 2021: $6.4B · 10-K 0001558370-22-000961 filed Feb 9, 2022Equity incl. NCI · Q1 2022: $6.5B · 10-Q 0001558370-22-006502 filed Apr 29, 2022Equity incl. NCI · Q2 2022: $6.5B · 10-Q 0001558370-22-011379 filed Jul 29, 2022Equity incl. NCI · Q3 2022: $6.6B · 10-Q 0001558370-22-015585 filed Oct 28, 2022Equity incl. NCI · Q4 2022: $7.1B · 10-K 0001558370-23-001036 filed Feb 8, 2023Equity incl. NCI · Q1 2023: $7.4B · 10-Q 0001558370-23-007328 filed Apr 28, 2023Equity incl. NCI · Q2 2023: $7.6B · 10-Q 0001558370-23-012484 filed Jul 28, 2023Equity incl. NCI · Q3 2023: $7.9B · 10-Q 0001558370-23-016952 filed Oct 27, 2023Equity incl. NCI · Q4 2023: $8.4B · 10-K 0001558370-24-000866 filed Feb 7, 2024Equity incl. NCI · Q1 2024: $8.7B · 10-Q 0001558370-24-005928 filed Apr 26, 2024Equity incl. NCI · Q2 2024: $9.0B · 10-Q 0001558370-24-010246 filed Jul 26, 2024Equity incl. NCI · Q3 2024: $9.5B · 10-Q 0001558370-24-013696 filed Oct 25, 2024Equity incl. NCI · Q4 2024: $9.8B · 10-K 0001558370-25-000714 filed Feb 7, 2025Equity incl. NCI · Q1 2025: $10.4B · 10-Q 0001558370-25-005558 filed Apr 25, 2025Equity incl. NCI · Q2 2025: $11.6B · 10-Q 0001558370-25-009610 filed Jul 25, 2025Equity incl. NCI · Q3 2025: $12.6B · 10-Q 0001104659-25-102142 filed Oct 24, 2025Equity incl. NCI · Q4 2025: $13.5B · 10-K 0001104659-26-013549 filed Feb 11, 2026Equity incl. NCI · Q1 2026: $14.1B · 10-Q 0001104659-26-054128 filed May 1, 2026Equity incl. NCI · Q2 2026: $15.6B · 10-Q 0001104659-26-089194 filed Jul 31, 20266.415.63.4Q1 2016Q2 2026Q4 2021
Q4 2021
6.4$B
All values (42)
PeriodValue ($B)Status
Q2 202615.6reported
Q1 202614.1reported
Q4 202513.5reported
Q3 202512.6reported
Q2 202511.6reported
Q1 202510.4reported
Q4 20249.8reported
Q3 20249.5reported
Q2 20249.0reported
Q1 20248.7reported
Q4 20238.4reported
Q3 20237.9reported
Q2 20237.6reported
Q1 20237.4reported
Q4 20227.1reported
Q3 20226.6reported
Q2 20226.5reported
Q1 20226.5reported
Q4 20216.4reported
Q3 20216.0reported
Q2 20215.8reported
Q1 20215.5reported
Q4 20205.5reported
Q3 20205.1reported
Q2 20204.8reported
Q1 20204.4reported
Q4 20194.6reported
Q3 20194.2reported
Q2 20194.2reported
Q1 20194.2reported
Q4 20184.1reported
Q3 20184.1reported
Q2 20183.8reported
Q1 20184.0reported
Q4 20174.0reported
Q3 20174.1reported
Q2 20173.9reported
Q1 20173.8reported
Q4 20163.7reported
Q3 20163.8reported
Q2 20163.6reported
Q1 20163.4reported

CSV with all sources · Technical ID: equity_total

More metrics for Amphenol
Sources & calculation
Value
$6.4B
Period
Q4 2021, ended Dec 31, 2021 · as of Dec 31, 2021 (balance as of date, not a sum)
Source
10-K, filed Feb 9, 2022 · 0001558370-22-000961
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$6.4BFeb 9, 202210-K 0001558370-22-000961reported · confidence 1. · current